InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Mylet Johanna, Chief Financial Officer. Director active across 1 companies, notably Poseida Therapeutics, Inc.. In total, 3 filings have been published. The latest transaction was disclosed on 1 March 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations3 total
050,000 shares0
Common Stock
SEC:0001209191-22-014376:0·
€2,7212,616 shares@ €1.0401100.0% of flow
Common Stock
SEC:0001209191-21-070938·
€2,7212,616 shares@ €1.040150.0% of flow
Common Stock
SEC:0001209191-21-070938:0·
3 of 3 declarations
About Mylet Johanna
Johanna Mylet is the Chief Financial Officer at Poseida Therapeutics, Inc. She is responsible for the financial management of the company, including financial planning and risk management. Her expertise in finance is essential to ensure the stability and growth of the organization.
